51
|
German DM, Kabir MM, Dewland TA, Henrikson CA, Tereshchenko LG. Atrial Fibrillation Predictors: Importance of the Electrocardiogram. Ann Noninvasive Electrocardiol 2015; 21:20-9. [PMID: 26523405 DOI: 10.1111/anec.12321] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2015] [Revised: 08/10/2015] [Accepted: 08/18/2015] [Indexed: 01/19/2023] Open
Abstract
Atrial fibrillation (AF) is the most common arrhythmia in adults and is associated with significant morbidity and mortality. Substantial interest has developed in the primary prevention of AF, and thus the identification of individuals at risk for developing AF. The electrocardiogram (ECG) provides a wealth of information, which is of value in predicting incident AF. The PR interval and P wave indices (including P wave duration, P wave terminal force, P wave axis, and other measures of P wave morphology) are discussed with regard to their ability to predict and characterize AF risk in the general population. The predictive value of the QT interval, ECG criteria for left ventricular hypertrophy, and findings of atrial and ventricular ectopy are also discussed. Efforts are underway to develop models that predict AF incidence in the general population; however, at present, little information from the ECG is included in these models. The ECG provides a great deal of information on AF risk and has the potential to contribute substantially to AF risk estimation, but more research is needed.
Collapse
Affiliation(s)
- David M German
- Department of Medicine, Oregon Health and Science University, Portland, OR
| | - Muammar M Kabir
- Department of Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR
| | - Thomas A Dewland
- Department of Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR
| | - Charles A Henrikson
- Department of Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR
| | - Larisa G Tereshchenko
- Department of Medicine, The Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR
| |
Collapse
|
52
|
Patel BB, Raad M, Sebag IA, Chalifour LE. Sex-specific cardiovascular responses to control or high fat diet feeding in C57bl/6 mice chronically exposed to bisphenol A. Toxicol Rep 2015; 2:1310-1318. [PMID: 28962473 PMCID: PMC5598525 DOI: 10.1016/j.toxrep.2015.09.008] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Accepted: 09/25/2015] [Indexed: 12/16/2022] Open
Abstract
The increased pericardial fat which often accompanies overall obesity is thought to alter cardiac structure/function and increase the risk for atrial fibrillation. We hypothesized that chronic exposure to bisphenol A (BPA) would induce pericardial fat, cardiac hypertrophy or arrhythmia. C57bl/6n dams were exposed to BPA (25 ng/ml drinking water) beginning on gestation day 11 and progeny continued on 2.5 ng BPA/ml drinking water. The progeny of control dams (VEH) and dams treated with diethylstilbestrol (DES, 1 μg/kg/day, gestation days 1114) had tap water. After weaning progeny were fed either a control (CD) or high fat diet (HFD) for 3 months. Pericardial fat was present in CD-BPA and CD-DES and not CD-VEH mice, and was increased in all HFD mice. Catecholamine challenge revealed no differences in males, but BPA-exposed females had longer P-wave and QRS complex duration. Only CD-BPA and CD-DES females developed cardiac hypertrophy which was independent of increased blood pressure. Calcium homeostasis protein expression changes in HFD-BPA and HFD-DES mice predict reduced SERCA2 activity in males and increased SERCA2 activity in females. Thus, chronic BPA exposure induced pericardial fat in the absence of HFD, and female-specific changes in cardiac hypertrophy development and cardiac electrical conduction after a catecholamine challenge.
Collapse
Affiliation(s)
- Bhavini B Patel
- Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, Quebec H3T 1E2, Canada
| | - Mohamad Raad
- Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, Quebec H3T 1E2, Canada
| | - Igal A Sebag
- Division of Cardiology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, Quebec H3T 1E2, Canada
| | - Lorraine E Chalifour
- Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, Quebec H3T 1E2, Canada.,Division of Cardiology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, Quebec H3T 1E2, Canada.,Division of Endocrinology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montréal, Québec H3T 1E2, Canada.,Division of Experimental Medicine, Department of Medicine, McGill University, 850 Sherbrooke Street, Montréal, Québec H3A 1A2, Canada
| |
Collapse
|
53
|
Martínez A, Abásolo D, Alcaraz R, Rieta JJ. Alteration of the P-wave non-linear dynamics near the onset of paroxysmal atrial fibrillation. Med Eng Phys 2015; 37:692-7. [PMID: 25956053 DOI: 10.1016/j.medengphy.2015.03.021] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2015] [Revised: 02/23/2015] [Accepted: 03/29/2015] [Indexed: 11/28/2022]
Abstract
The analysis of P-wave variability from the electrocardiogram (ECG) has been suggested as an early predictor of the onset of paroxysmal atrial fibrillation (PAF). Hence, a preventive treatment could be used to avoid the loss of normal sinus rhythm, thus minimising health risks and improving the patient's quality of life. In these previous studies the variability of different temporal and morphological P-wave features has been only analysed in a linear fashion. However, the electrophysiological alteration occurring in the atria before the onset of PAF has to be considered as an inherently complex, chaotic and non-stationary process. This work analyses the presence of non-linear dynamics in the P-wave progression before the onset of PAF through the application of the central tendency measure (CTM), which is a non-linear metric summarising the degree of variability in a time series. Two hour-length ECG intervals just before the arrhythmia onset belonging to 46 different PAF patients were analysed. In agreement with the invasively observed inhomogeneous atrial conduction preceding the onset of PAF, CTM for all the considered P-wave features showed higher variability when the arrhythmia was closer to its onset. A diagnostic accuracy around 80% to discern between ECG segments far from PAF and close to PAF was obtained with the CTM of the metrics considered. This result was similar to previous P-wave variability methods based on linear approaches. However, the combination of linear and non-linear methods with a decision tree improved considerably their discriminant ability up to 90%, thus suggesting that both dynamics could coexist at the same time in the fragmented depolarisation of the atria preceding the arrhythmia.
Collapse
Affiliation(s)
- Arturo Martínez
- Research Group in Electronic, Biomedical and Telecommunication Engineering, University of Castilla-La Mancha, Spain
| | - Daniel Abásolo
- Centre for Biomedical Engineering, Department of Mechanical Engineering Sciences, University of Surrey, UK
| | - Raúl Alcaraz
- Research Group in Electronic, Biomedical and Telecommunication Engineering, University of Castilla-La Mancha, Spain.
| | - José J Rieta
- Biomedical Synergy, Electronic Engineering Department, Universidad Politécnica de Valencia, Spain
| |
Collapse
|
54
|
Alcaraz R, Martínez A, Rieta JJ. Role of the P-wave high frequency energy and duration as noninvasive cardiovascular predictors of paroxysmal atrial fibrillation. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2015; 119:110-119. [PMID: 25758369 DOI: 10.1016/j.cmpb.2015.01.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/14/2014] [Revised: 12/14/2014] [Accepted: 01/21/2015] [Indexed: 06/04/2023]
Abstract
A normal cardiac activation starts in the sinoatrial node and then spreads throughout the atrial myocardium, thus defining the P-wave of the electrocardiogram. However, when the onset of paroxysmal atrial fibrillation (PAF) approximates, a highly disturbed electrical activity occurs within the atria, thus provoking fragmented and eventually longer P-waves. Although this altered atrial conduction has been successfully quantified just before PAF onset from the signal-averaged P-wave spectral analysis, its evolution during the hours preceding the arrhythmia has not been assessed yet. This work focuses on quantifying the P-wave spectral content variability over the 2h preceding PAF onset with the aim of anticipating as much as possible the arrhythmic episode envision. For that purpose, the time course of several metrics estimating absolute energy and ratios of high- to low-frequency power in different bands between 20 and 200Hz has been computed from the P-wave autoregressive spectral estimation. All the analyzed metrics showed an increasing variability trend as PAF onset approximated, providing the P-wave high-frequency energy (between 80 and 150Hz) a diagnostic accuracy around 80% to discern between healthy subjects, patients far from PAF and patients less than 1h close to a PAF episode. This discriminant power was similar to that provided by the most classical time-domain approach, i.e., the P-wave duration. Furthermore, the linear combination of both metrics improved the diagnostic accuracy up to 88.07%, thus constituting a reliable noninvasive harbinger of PAF onset with a reasonable anticipation. The information provided by this methodology could be very useful in clinical practice either to optimize the antiarrhythmic treatment in patients at high-risk of PAF onset and to limit drug administration in low risk patients.
Collapse
Affiliation(s)
- Raúl Alcaraz
- Innovation in Bioengineering Research Group, University of Castilla-La Mancha, Spain..
| | - Arturo Martínez
- Innovation in Bioengineering Research Group, University of Castilla-La Mancha, Spain
| | - José J Rieta
- Biomedical Synergy, Electronic Engineering Department, Universidad Politécnica de Valencia, Spain
| |
Collapse
|
55
|
Hoshino T, Nagao T, Shiga T, Maruyama K, Toi S, Mizuno S, Ishizuka K, Shimizu S, Uchiyama S, Kitagawa K. Prolonged QTc Interval Predicts Poststroke Paroxysmal Atrial Fibrillation. Stroke 2015; 46:71-6. [DOI: 10.1161/strokeaha.114.006612] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Background and Purpose—
Paroxysmal atrial fibrillation (PAF) is often difficult to detect in patients with acute ischemic stroke. We aimed to assess the predictive value of a prolonged QT interval corrected for heart rate (QTc) in PAF detection after acute ischemic stroke.
Methods—
We enrolled 972 patients with acute ischemic stroke consecutively extracted from our observational stroke registry system. Exclusion criteria were as follows: (1) AF on the initial 12-lead ECG (n=171); (2) previously diagnosed PAF (n=47); and (3) the use of a cardiac pacemaker (n=10). Of the 972 patients, 744 (mean age, 67.6 years; men, 62.6%) were eligible for analysis. The clinical characteristics and 12-lead ECG findings of the patients with and without PAF were compared, and multiple logistic regression analysis was performed to identify predictors of poststroke PAF.
Results—
The poststroke cardiac work-up yielded 69 (9.3%) de novo PAF cases among the 744 patients. The QTc interval was significantly longer in patients with PAF than in those without PAF (436 versus 417 ms;
P
<0.001). Each 10-ms increase in the QTc interval was associated with an increased risk of PAF after multivariate adjustments (odds ratio, 1.41; 95% confidence interval, 1.24–1.61;
P
<0.001). The optimal threshold value of QTc interval calculated by a receiver-operating characteristic curve was 438 ms, and the area under the curve was 0.73 in this data set.
Conclusions—
The QTc interval prolongation is potentially a strong and useful predictor for poststroke PAF.
Collapse
Affiliation(s)
- Takao Hoshino
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Takehiko Nagao
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Tsuyoshi Shiga
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Kenji Maruyama
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Sono Toi
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Satoko Mizuno
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Kentaro Ishizuka
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Satoru Shimizu
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Shinichiro Uchiyama
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| | - Kazuo Kitagawa
- From the Department of Neurology (T.H., T.N., K.M., S.T., S.M., K.I., S.U., K.K.), Department of Cardiology (T.S.), and Medical Research Institute (S.S.), Tokyo Women’s Medical University, Tokyo, Japan; Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); and Center for Brain and Cerebral Vessels, Sanno Hospital Sanno Medical Center, Tokyo, Japan (S.U.)
| |
Collapse
|
56
|
Magnani JW, Zhu L, Lopez F, Pencina MJ, Agarwal SK, Soliman EZ, Benjamin EJ, Alonso A. P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2015; 169:53-61.e1. [PMID: 25497248 DOI: 10.1016/j.ahj.2014.10.009] [Citation(s) in RCA: 64] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2014] [Accepted: 10/09/2014] [Indexed: 10/24/2022]
Abstract
BACKGROUND Atrial fibrillation (AF) is associated with increased morbidity. P-wave indices (PWIs) measure atrial electrical function and are associated with AF. Study of PWI has been limited to single-cohort investigations, and their contributions to risk enhancement are unknown. METHODS We examined PWI from the FHS and ARIC study. We calculated 10-year AF risk using adjusted Cox models. We conducted cross-cohort meta-analyses for the PWI estimates and assessed their contributions to risk discrimination (c statistic), net reclassification index, and integrated discrimination improvement. RESULTS After exclusions, the analysis included 3,110 FHS (62.6 ± 9.8 years, 56.9% women) and 8,254 ARIC participants (62.3 ± 5.6 years, 57.3% women, 20.3% black race). Over 10 years, 217 FHS and 458 ARIC participants developed AF. In meta-analysis, P-wave duration >120 milliseconds was significantly associated with AF (hazard ratio 1.55, 95% CI 1.29-1.85) compared with ≤120 milliseconds. P-wave area was marginally but not significantly related to AF (hazard ratio 1.31, 95% CI 0.95-1.80). P-wave terminal force was strongly associated with AF in ARIC but not FHS. P-wave indices had a limited contribution toward predictive risk beyond traditional risk factors and markers. CONCLUSIONS P-wave indices are intermediate phenotypes for AF. They are associated with AF in cross-cohort meta-analyses but contribute minimally toward enhancing risk prediction.
Collapse
|
57
|
Eranti A, Aro AL, Kerola T, Anttonen O, Rissanen HA, Tikkanen JT, Junttila MJ, Kenttä TV, Knekt P, Huikuri HV. Prevalence and Prognostic Significance of Abnormal P Terminal Force in Lead V
1
of the ECG in the General Population. Circ Arrhythm Electrophysiol 2014; 7:1116-21. [DOI: 10.1161/circep.114.001557] [Citation(s) in RCA: 66] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Antti Eranti
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Aapo L. Aro
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Tuomas Kerola
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Olli Anttonen
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Harri A. Rissanen
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Jani T. Tikkanen
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - M. Juhani Junttila
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Tuomas V. Kenttä
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Paul Knekt
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| | - Heikki V. Huikuri
- From the Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (A.E., T.K., O.A.); Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital (A.L.A.) and Department of Health, Functional Capacity and Welfare, National Institute of Health and Welfare (H.A.R., P.K.), Helsinki, Finland; and Department on Internal Medicine, Institute of Clinical Medicine, Medical Research Center Oulu, University Hospital & University of Oulu, Oulu, Finland (J.T.T., M
| |
Collapse
|
58
|
Huo Y, Holmqvist F, Carlson J, Gaspar T, Hindricks G, Piorkowski C, Bollmann A, Platonov PG. Variability of P-wave morphology predicts the outcome of circumferential pulmonary vein isolation in patients with recurrent atrial fibrillation. J Electrocardiol 2014; 48:218-25. [PMID: 25555742 DOI: 10.1016/j.jelectrocard.2014.11.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2014] [Indexed: 10/24/2022]
Abstract
INTRODUCTION Severe atrial structural remodeling may reflect irreversible damage of the atrial tissue in patients with atrial fibrillation (AF) and is associated with changes of P-wave duration and morphology. Our aim was to study whether variability of P-wave morphology (PMV) is associated with outcome in patients with AF after circumferential PV isolation (CPVI). METHODS AND RESULTS 70 consecutive patients (aged 60±9years, 46 men) undergoing CPVI due to symptomatic AF were studied. After cessation of antiarrhythmic therapy, standard 12-lead ECG during sinus rhythm was recorded for 10min at baseline and transformed to orthogonal leads. Beat-to-beat P-wave morphology was subsequently defined using a pre-defined classification algorithm. The most commonly observed P-wave morphology in a patient was defined as the dominant morphology. PMV was defined as the percentage of P waves with non-dominant morphology in the 10-min sample. At the end of follow-up, 53 of 70 patients had no arrhythmia recurrence. PMV was greater in patients without recurrence (19.5±17.1% vs. 8.2±6.7%, p<0.001). In the multivariate logistic regression model, PMV≥20% (upper tertile) was the only independent predictor of ablation success (OR=11.4, 95% CI 1.4-92.1, p=0.023). A PMV≥20% demonstrated a sensitivity of 41.5%, a specificity of 94.1%, a PPV of 96.7%, and an NPV of 34.0% for free of AF after CPVI. CONCLUSIONS We report a significant association between increased PMV and 6-month CPVI success. PMV may help to identify patients with very high likelihood of freedom of AF 6-months after CPVI.
Collapse
Affiliation(s)
- Yan Huo
- Department of Cardiology and Center for Integrative Electrocardiology at Lund University (CIEL), Lund University, Lund, Sweden; Department of Electrophysiology, Heart Center-University Dresden, Dresden, Germany.
| | - Fredrik Holmqvist
- Department of Cardiology and Center for Integrative Electrocardiology at Lund University (CIEL), Lund University, Lund, Sweden
| | - Jonas Carlson
- Department of Cardiology and Center for Integrative Electrocardiology at Lund University (CIEL), Lund University, Lund, Sweden
| | - Thomas Gaspar
- Department of Electrophysiology, Heart Center-University Dresden, Dresden, Germany
| | - Gerhard Hindricks
- Department of Electrophysiology, Heart Center-University Leipzig, Leipzig, Germany
| | | | - Andreas Bollmann
- Department of Electrophysiology, Heart Center-University Leipzig, Leipzig, Germany
| | - Pyotr G Platonov
- Department of Cardiology and Center for Integrative Electrocardiology at Lund University (CIEL), Lund University, Lund, Sweden
| |
Collapse
|
59
|
Alcaraz R, Martínez A, Rieta JJ. The P Wave Time-Frequency Variability Reflects Atrial Conduction Defects before Paroxysmal Atrial Fibrillation. Ann Noninvasive Electrocardiol 2014; 20:433-45. [PMID: 25418673 DOI: 10.1111/anec.12240] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND The study of atrial conduction defects associated with the onset of paroxysmal atrial fibrillation (PAF) can be addressed by analyzing the P wave from the surface electrocardiogram (ECG). Traditionally, signal-averaged ECGs have been mostly used for this purpose. However, this alternative hinders the possibility to quantify every single P wave, its variability over time, as well as to obtain complimentary and evolving information about the arrhythmia. This work analyzes the time progression of several time and frequency P wave features as potential indicators of atrial conduction variability several hours preceding the onset of PAF. METHODS The longest sinus rhythm interval from 24-hour Holter recordings of 46 PAF patients was selected. Next, the 2 hours before the onset of PAF were extracted and divided into two 1-hour periods. Every single P wave was automatically delineated and characterized by 16 time and frequency metrics, such as its duration, absolute energy in several frequency bands and high-to-low-frequency energy ratios. Finally, the P wave variability over each 1-hour period was estimated from the 16 features making use of a least-squares linear fitting. As a reference, the same parameters were also estimated from a set of 1-hour ECG segments randomly chosen from a control group of 53 healthy subjects age-, gender-, and heart rate-matched. RESULTS All the analyzed metrics provided an increasing P wave variability trend as the onset of PAF approximated, being P wave duration and P wave high-frequency energy the most significant individual metrics. The linear fitting slope α associated with P wave duration was (2.48 ± 1.98)×10(-2) for healthy subjects, (23.8 ± 14.1)×10(-2) for ECG segments far from PAF and for (81.8 ± 48.7)×10(-2) ECG segments close to PAF p = 6.96×10(-22) . Similarly, the P wave high-frequency energy linear fitting slope was (2.42 ± 4.97)×10(-9) , (54.2 ± 107.1)×10(-9) and (274.2 ± 566.1)×10(-9) , respectively (p = 2.85×10(-20) ). A univariate discriminant analysis provided that both P wave duration and P wave high-frequency energy could discern among the three ECG sets with diagnostic ability around 80%, which was improved up to 88% by combining these metrics in a multivariate discriminant analysis. CONCLUSION Alterations in atrial conduction can be successfully quantified several hours before the onset of PAF by estimating variability over time of several time and frequency P wave features.
Collapse
Affiliation(s)
- Raúl Alcaraz
- Innovation in Bioengineering Research Group, University of Castilla-La Mancha, Cuenca, Spain
| | - Arturo Martínez
- Innovation in Bioengineering Research Group, University of Castilla-La Mancha, Cuenca, Spain
| | - José J Rieta
- Biomedical Synergy, Electronic Engineering Department, Universidad Politécnica de Valencia, Valencia, Spain
| |
Collapse
|
60
|
Martínez A, Alcaraz R, Rieta JJ. Gaussian modeling of the P-wave morphology time course applied to anticipate paroxysmal atrial fibrillation. Comput Methods Biomech Biomed Engin 2014; 18:1775-84. [PMID: 25298113 DOI: 10.1080/10255842.2014.964219] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
This paper introduces a new algorithm to quantify the P-wave morphology time course with the aim of anticipating as much as possible the onset of paroxysmal atrial fibrillation (PAF). The method is based on modeling each P-wave with a single Gaussian function and analyzing the extracted parameters variability over time. The selected Gaussian approaches are associated with the amplitude, peak timing, and width of the P-wave. In order to validate the algorithm, electrocardiogram segments 2 h preceding the onset of PAF episodes from 46 different patients were assessed. According to the expected intermittently disturbed atrial conduction before the onset of PAF, all the analyzed Gaussian metrics showed an increasing variability trend as the PAF onset approximated. Moreover, the Gaussian P-wave width reported a diagnostic accuracy around 80% to discern between healthy subjects, patients far from PAF, and patients less than 1 h close to a PAF episode. This discriminant power was similar to those provided by the most classical time-domain approach, i.e., the P-wave duration. However, this newly proposed parameter presents the advantage of being less sensitive to a precise delineation of the P-wave boundaries. Furthermore, the linear combination of both metrics improved the diagnostic accuracy up to 86.69%. In conclusion, morphological P-wave characterization provides additional information to the metrics based on P-wave timing.
Collapse
Affiliation(s)
- Arturo Martínez
- a Innovation in Bioengineering Research Group , University of Castilla-La Mancha , Cuenca , Spain
| | | | | |
Collapse
|
61
|
Francia P, Ricotta A, Balla C, Adduci C, Semprini L, Frattari A, Modestino A, Mercanti F, Sensini I, Caprinozzi M, Tocci G, Volpe M. P-wave duration in lead aVR and the risk of atrial fibrillation in hypertension. Ann Noninvasive Electrocardiol 2014; 20:167-74. [PMID: 25200638 DOI: 10.1111/anec.12197] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Hypertension entails atrial remodeling that affect P-wave (PW) duration on electrocardiogram (ECG). PW indices (e.g., variance, dispersion, and terminal force) are associated with a higher risk for atrial fibrillation (AF), but their calculation requires multiple measurements of PW duration, limiting their use in clinical practice. We evaluated whether PW duration in specific ECG leads may identify patients with increased susceptibility to AF in a population of hypertensive patients. METHODS In a case-control study, AF and control subjects were matched for age, sex, and left atrial (LA) dimensions. PW duration was measured from digitally stored ECGs. Logistic regression was used to assess the association of PW duration and indices with AF. RESULTS We enrolled 44 hypertensive AF patients (16 paroxysmal and 28 persistent) and 44 hypertensive controls. AF and control subjects were matched for sex (males, n = 27), age (67 ± 8 years), LA diameter (40 ± 5 mm), and were comparable for left ventricular mass (45 ± 11 g/m(2.7) vs 48 ± 12 g/m(2.7) , P = 0.19), ejection fraction (58 ± 7% in both groups), and prevalence of mild valvular heart disease (7% vs 5%; P = 0.64). PW duration in lead aVR was significantly higher in AF patients as compared with controls (115 ± 18 ms vs 101 ± 14 ms; P < 0.0001) and was the best independent predictor of AF in multivariable logistic regression (PW ≥ 100 ms: RR = 3.7; 95% CI: 1.3-10.3; P = 0.02). CONCLUSIONS Simple measurement of PW duration in lead aVR allows effective identification of AF patients in a population of hypertensives. Confirmation of this finding in a larger population would provide a simple and effective risk marker of AF in hypertensive patients.
Collapse
Affiliation(s)
- Pietro Francia
- Division of Cardiology, Department of Clinical and Molecular Medicine, St. Andrea Hospital, Sapienza University, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
62
|
Tereshchenko LG, Shah AJ, Li Y, Soliman EZ. Electrocardiographic deep terminal negativity of the P wave in V1 and risk of mortality: the National Health and Nutrition Examination Survey III. J Cardiovasc Electrophysiol 2014; 25:1242-8. [PMID: 24837486 DOI: 10.1111/jce.12453] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 05/05/2014] [Accepted: 05/12/2014] [Indexed: 11/28/2022]
Abstract
INTRODUCTION Deep terminal negativity of P wave in V1 (DTNPV1), defined as negative P prime larger than one small box (1 mm, or 0.1 mV), could be easily detected by simple visual inspection of the resting 12-lead ECG. The objective of this study was to determine the relationship between DTNPV1 and all-cause-, cardiovascular disease (CVD), and ischemic heart disease (IHD) mortality in the National Health and Nutrition Examination Survey III (NHANES III). METHODS AND RESULTS After exclusion of participants with atrial fibrillation and missing data, DTNPV1 was automatically measured from standard 12-lead ECG in 8,146 participants. Minnesota and Novacode algorithms were used for the determination of major and minor ECG abnormalities. National Death Index was used to identify the date and cause of death. During a median follow-up of 13.8 years, a total of 2,975 deaths (1,303 CVD and 742 IHD deaths) occurred. After adjustment for age, gender, race/ethnicity, IHD, heart failure, chronic obstructive pulmonary disease, cancer, diabetes, body mass index, smoking, dyslipidemia, hypertension, use of antihypertensive and lipid-lowering medications, and ECG abnormalities, DTNPV1 was associated with significantly increased risk of all-cause death (HR [95% CI]: 1.30 [1.10, 1.53]; P = 0.002), CVD death (HR [95% CI]: 1.36 [1.08, 1.72]; P = 0.010), and IHD death (HR [95% CI]: 1.36 [1.00, 1.85]; P = 0.047). CONCLUSION In a large sample of the adult United States population, DTNPV1 is independently associated with increased risk of death due to all-cause, CVD, and IHD, findings suggesting its potential usefulness as a simple marker to identify individuals at risk of poor outcomes.
Collapse
Affiliation(s)
- Larisa G Tereshchenko
- Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA
| | | | | | | |
Collapse
|
63
|
Friedman DJ, Wang N, Meigs JB, Hoffmann U, Massaro JM, Fox CS, Magnani JW. Pericardial fat is associated with atrial conduction: the Framingham Heart Study. J Am Heart Assoc 2014; 3:e000477. [PMID: 24595189 PMCID: PMC4187474 DOI: 10.1161/jaha.113.000477] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Background Obesity is associated with altered atrial electrophysiology and a prominent risk factor for atrial fibrillation. Body mass index, the most widely used adiposity measure, has been related to atrial electrical remodeling. We tested the hypothesis that pericardial fat is independently associated with electrocardiographic measures of atrial conduction. Methods and Results We performed a cross‐sectional analysis of 1946 Framingham Heart Study participants (45% women) to determine the relation between pericardial fat and atrial conduction as measured by P wave indices (PWI): PR interval, P wave duration (P‐duration), P wave amplitude (P‐amplitude), P wave area (P‐area), and P wave terminal force (P‐terminal). We performed sex‐stratified linear regression analyses adjusted for relevant clinical variables and ectopic fat depots. Each 1‐SD increase in pericardial fat was significantly associated with PR interval (β=1.7 ms, P=0.049), P‐duration (β=2.3 ms, P<0.001), and P‐terminal (β=297 μV·ms, P<0.001) among women; and P‐duration (β=1.2 ms, P=0.002), P‐amplitude (β=−2.5 μV, P<0. 001), and P‐terminal (β=160 μV·ms, P=0.002) among men. Among both sexes, pericardial fat was significantly associated with P‐duration in analyses additionally adjusting for visceral fat or intrathoracic fat; a similar but non‐significant trend existed with P‐terminal. Among women, pericardial fat was significantly associated with P wave area after adjustment for visceral and intrathoracic fat. Conclusions Pericardial fat is associated with atrial conduction as quantified by PWI, even with adjustment for extracardiac fat depots. Further studies are warranted to identify the mechanisms through which pericardial fat may modify atrial electrophysiology and promote subsequent risk for arrhythmogenesis.
Collapse
|
64
|
Conde D, Baranchuk A. [Interatrial block as anatomical-electrical substrate for supraventricular arrhythmias: Bayés syndrome]. ARCHIVOS DE CARDIOLOGIA DE MEXICO 2014; 84:32-40. [PMID: 24529591 DOI: 10.1016/j.acmx.2013.10.004] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2013] [Revised: 10/23/2013] [Accepted: 10/23/2013] [Indexed: 12/17/2022] Open
Abstract
In this article we aimed to establish that interatrial block exists as an anatomical-electrical entity, which should be considered a true block. Interatrial block presents with different degrees as other blocks in the conduction system. It shows a correlation with the left atrium size, however, it can be seen in patients with normal atrial size too. Interatrial block is strongly associated with atrial arrhythmias and it could be considered a predictor of cardioembolic stroke. Interatrial block is an expression of atrial electrical remodeling and dysfunction. IAB can be transient and in certain clinical circumstances, may be reversible. The contribution of endocardial mapping has increased our knowledge of the anatomy and pathophysiology of interatrial block. Magnetocardiography could be a possible non-invasive procedure to further investigate this entity. The interatrial block classification should include first, second and third degree or alternatively, in order to simplify the terminology: partial or advanced. The P wave morphology should always be taking into consideration when diagnosing this condition. Finally, without the initial description of interatrial block made by Dr. Bayés de Luna, it would be impossible to understand interatrial block as an anatomical and electrical substrate for atrial arrhythmias. It is our opinion that this represents a major contribution to the knowledge of electrocardiography and electrophysiology, and makes commendable that this arrhythmic syndrome should be called «Bayés' syndrome»
Collapse
Affiliation(s)
- Diego Conde
- Cardiology Division, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
| | - Adrián Baranchuk
- Cardiology Division, Kingston General Hospital, Queen' University, Kingston, Ontario, Canada
| |
Collapse
|
65
|
Martínez A, Alcaraz R, Rieta JJ. Morphological variability of the P-wave for premature envision of paroxysmal atrial fibrillation events. Physiol Meas 2013; 35:1-14. [PMID: 24345763 DOI: 10.1088/0967-3334/35/1/1] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
66
|
Seaborn GEJ, Todd K, Michael KA, Baranchuk A, Abdollah H, Simpson CS, Akl SG, Redfearn DP. Heart rate variability and procedural outcome in catheter ablation for atrial fibrillation. Ann Noninvasive Electrocardiol 2013; 19:23-33. [PMID: 24112475 DOI: 10.1111/anec.12098] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
INTRODUCTION In patients with normal hearts, increased vagal tone is associated with onset of paroxysmal atrial fibrillation (AF). Vagal denervation of the atria renders AF less inducible. Circumferential pulmonary vein isolation (CPVI) is effective for treating paroxysmal and persistent AF, and has been shown to impact heart rate variability (HRV) indices, in turn, reflecting vagal denervation. We examined the impact of CPVI on HRV indices, and evaluated the relationship between vagal modification and AF recurrence. METHODS Electrocardiogram recordings were collected from 83 consecutive patients (63 male, 20 female, age 56.9 ± 9.3 years) undergoing CPVI for paroxysmal (n = 56) or persistent (n = 27) AF. Recordings were obtained over 10 minutes preprocedure, and at intervals up to 12 months. Antiarrhythmic medications were suspended prior to CPVI, and were resumed for 3 months following. Success was defined as no recurrence of atrial arrhythmia lasting longer than 30 seconds. RESULTS In patients with successful procedures (n = 56, 42 paroxysmal, 14 persistent), HRV indices were significantly altered, with respect to preprocedure levels, over a sustained period. However, patients with recurrence (n = 27, 14 paroxysmal, 13 persistent) demonstrated similar HRV to their preprocedure levels over the follow-up period. CONCLUSION Our results suggest that patients experiencing recurrence after a single CPVI have HRV attenuated by the procedure only intermittently, whereas patients with one successful CPVI experience a sustained change. A short-term HRV recording is a convenient and potentially important marker for recurrence of atrial arrhythmia in a population undergoing CPVI.
Collapse
Affiliation(s)
- Geoffrey E J Seaborn
- Division of Cardiology (Arrhythmia Service), Kingston General Hospital, Queen's University, Kingston, Ontario, Canada
| | | | | | | | | | | | | | | |
Collapse
|